Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
66.36
-1.17 (-1.73%)
At close: Nov 10, 2026, 4:00 PM EST
66.58
+0.22 (0.33%)
After-hours: Nov 10, 2026, 7:30 PM EST

Vaxcyte Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
125.47173.96387.88397.45834.6668.99
Short-Term Investments
1,1671,3871,359682.7896.72176.99
Cash & Short-Term Investments
1,2921,5611,7471,080931.38245.97
Cash Growth
-24.49%-10.66%61.75%15.98%278.65%-36.31%
Other Receivables
-46.5623.083.63.881.2
Receivables
-46.5623.083.63.881.2
Prepaid Expenses
57.3317.0415.736.165.319.18
Other Current Assets
-2.81.965.971.99-
Total Current Assets
1,3501,6271,7881,096942.56256.35
Property, Plant & Equipment
662.93373.38270.15110.6231.6535.91
Long-Term Investments
972.16881.661,388162.6826.5527.12
Long-Term Deferred Charges
-----0.5
Other Long-Term Assets
4.5120.3165.6838.675.434.46
Total Assets
2,9893,0033,5111,4081,006324.34

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
67.6170.948.4514.599.86.76
Accrued Expenses
210.47128.7285.84123.6424.8216.68
Current Portion of Leases
17.616.125.897.115.915.28
Total Current Liabilities
295.7205.75140.18145.3440.5328.72
Long-Term Leases
204.22111.3665.2222.1112.0311.51
Other Long-Term Liabilities
-0.10.1-0.010.1
Total Liabilities
499.92317.21205.5167.4552.5740.32

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.150.130.130.10.080.06
Additional Paid-In Capital
5,5614,8394,6982,1651,476582.84
Retained Earnings
-3,057-2,155-1,388-924.39-522.13-298.64
Comprehensive Income & Other
-14.981.59-3.870.18-0.36-0.24
Total Common Equity
2,4892,6863,3061,240953.61284.02
Shareholders' Equity
2,4892,6863,3061,240953.61284.02
Total Liabilities & Equity
2,9893,0033,5111,4081,006324.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
221.84117.4871.1129.2217.9416.78
Net Cash (Debt)
1,0701,4431,6761,051913.44229.19
Net Cash Growth
-34.21%-13.88%59.48%15.06%298.55%-40.66%
Net Cash Per Share
7.5210.6113.7410.8214.084.41
Filing Date Shares Outstanding
158.3143.92128.76108.4180.0356.31
Total Common Shares Outstanding
149.3131.06124.8995.3679.4753.03
Working Capital
1,0541,4221,648950.62902.03227.63
Book Value Per Share
16.6720.4926.4713.0112.005.36
Tangible Book Value
2,4892,6863,3061,240953.61284.02
Tangible Book Value Per Share
16.6720.4926.4713.0112.005.36
Machinery
213.5565.8258.1535.6215.1211.5
Construction In Progress
10.67217.08151.7951.82--
Leasehold Improvements
73.337.244.381.461.35-
SEC Filings: 10-K · 10-Q